TrialFind
Saved trials
Back to results
Unknown
Phase 2
TCHP Versus EC -THP as Neoadjuvant Treatment for HER2-Positive Breast Cancer
NCT04094896
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Guangdong General Hospital
Guangzhou, China
Contact
Kung Wang, MD
: 00862083827812
gzwangkun@126.com
View on ClinicalTrials.gov
Official details
TCHP Versus EC -THP as Neoadjuvant Treatment for HER2-Positive Breast Cancer — TrialFind